Gilenya: new MS drug approved by Health CanadaHealth Canada approves first disease-modifying oral treatment for multiple sclerosis in Canada. Long-term PPI use may cause serious hypomagnesemiaU.S. FDA communicating safety concerns regarding potential development of hypomagnesemia when PPIs taken for prolonged periods. Cardiology | Drink to your health How could the federal government improve healthcare? Audience at CMA/Maclean’s event favours EHR, pharmacare Is money war on in Alberta? Government wants to kill hard-won AMA programs, services for members New drug fights C. diff with fewer recurrences Question remains about whether treatment period should be extended Obesity | Patients really do heed your weight-loss advice Pharmacist immunization off the table in Ontario, for now The Ontario College of Pharmacists has decided not to pursue full immunization authority at this time. Osteoporosis | Canadian study confirms link between bisphosphonates and fracture risk Ottawa spending $40 million on rural FP residencies PICTURE YOURSELF: Spreading the gospel! Rinse and spit away preterm birth risk Mouthwash is good for more than just gums, study shows First Previous 1777 1778 1779 1780 1781 Next Last
